Abstract
To investigate whether recombinant human insulin-like growth factor-I (rhIGF-I) has direct effects on the insulin requirement to maintain euglycemia independent of the growth hormone (GH) level, nine subjects with insulin-dependent diabetes mellitus ([IDDM] seven females; median (range) age, duration of diabetes, and hemoglobin A1C [HbA1C], 16.9 (12.5 to 21.9) years, 11.8 (4.6 to 16.8) years, and 9.8% (7.9% to 14.1%), respectively) underwent two euglycemic studies (6:00 PM to 8:00 AM) after double-blind subcutaneous administration of rhIGF-I/placebo (40 microg/kg). Octreotide infusion (300 ng/kg/h) suppressed endogenous GH, and three identical discrete GH pulses were infused on both nights. Variable-rate insulin infusion maintained euglycemia. Samples were taken every 15 minutes (glucose and GH), 30 minutes (insulin and intermediate metabolites), and 60 minutes (IGF-I and nonesterified fatty acids [NEFA]). Variables were analyzed during the steady-state period of euglycemia (4:00 to 8:00 AM). Data are expressed as the mean +/- SEM. The insulin infusion rate and free-insulin level were both significantly reduced after rhIGF-I administration (0.13 +/- 0.03 v placebo 0.23 +/- 0.05 mU/kg/min, P = .04, and 8.4 +/- 1.3 v placebo 12.1...Continue Reading
References
Nov 1, 1991·The Journal of Clinical Endocrinology and Metabolism·J A BatchG Werther
Jul 1, 1991·Diabetologia·J FowelinI Lager
Nov 1, 1991·Metabolism: Clinical and Experimental·M BeylotR Mornex
Nov 1, 1990·The Journal of Clinical Endocrinology and Metabolism·J A EdgeC P Smith
Jan 1, 1990·Diabetologia·G PerrielloG B Bolli
Jan 1, 1987·Acta Endocrinologica. Supplementum·R S AarsenA G Harris
Oct 1, 1987·The Journal of Clinical Endocrinology and Metabolism·J BolinderP Arner
Jul 24, 1986·The New England Journal of Medicine·S A AmielW V Tamborlane
Apr 1, 1985·Diabetes·J R BrennanW G Blackard
Mar 22, 1984·The New England Journal of Medicine·G B Bolli, J E Gerich
Aug 1, 1994·The Journal of Endocrinology·T D CheethamD B Dunger
Apr 1, 1994·Clinical Endocrinology·T D CheethamD B Dunger
Jul 1, 1993·Diabetologia·T D CheethamD B Dunger
Citations
Jul 4, 1998·Lancet·C L AceriniD B Dunger
Apr 21, 1999·Clinical Endocrinology·P V CarrollD L Russell-Jones
Apr 1, 1997·Annals of Surgery·A P HoudijkP A van Leeuwen
Jan 4, 2007·Diabetes, Obesity & Metabolism·K C J Yuen, D B Dunger
Mar 12, 2005·Hormone Research·David DungerKen Ong
May 12, 2005·Hormone Research·Robert J FerryLorraine E Levitt Katz
Sep 1, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Jan Frystyk
Apr 21, 2006·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kevin C J Yuen, David B Dunger
Mar 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Rachel M WilliamsDavid B Dunger
Sep 10, 2003·Endocrinology·Frank WeekersGreet Van den Berghe
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·E C CrowneD B Dunger
Apr 12, 2007·The Journal of Clinical Endocrinology and Metabolism·D R ClemmonsA Sommer
Mar 4, 2000·Journal of Cellular Physiology·A Grimberg, P Cohen
Sep 1, 2006·Expert Review of Endocrinology & Metabolism·Rakesh Amin, David B Dunger